World Journal of Clinical Cases - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Moura CS, Etingin A, Lukusa L, Singh H, Narula N, Targownik LE, Leung Y, Zezos P, Polewiczowska-Nowak B, Afif W, Bernatsky S. Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars. World J Gastroenterol 2026; 32(9): 114580 [PMID: 41810446 DOI: 10.3748/wjg.v32.i9.114580]
URL:	https://www.wjgnet.com/2307-8960/full/v32/i9/114580.htm

(43) (34) (0) (0) (0) (654) (1)

Number	Citing Articles
1	Chuong Dinh Nguyen, Luan Minh Dang. Biosimilars in inflammatory bowel disease: Beyond evidence, toward trust and implementation. World Journal of Gastroenterology 2026; 32(28): 119462 doi: 10.3748/wjg.119462 Abstract(17) \| Core Tip(15) \| Full Article(HTML)(230) \| Full Article (PDF)-1084K(19) \| Full Article with Cover (PDF)-1358K(10) \| Full Article (XML)-199K(7) \| Audio-516K(0) \| Peer-Review Report-223K(9) \| Answering Reviewers-114K(6) \| Times Cited (0) \| Total Visits (294) \| Open

Number

Citing Articles

Chuong Dinh Nguyen, Luan Minh Dang. Biosimilars in inflammatory bowel disease: Beyond evidence, toward trust and implementation. World Journal of Gastroenterology 2026; 32(28): 119462 doi: 10.3748/wjg.119462

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.